These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1978470

  • 1. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R, Soni S, Rastogi SC, Levine S, Plant I, Edwards JG, Mitchell M, Chanas A.
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [Abstract] [Full Text] [Related]

  • 2. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG, Rimön R, Appelberg B, Hagert U, Harma P, Katila H, Mahlanen A, Mehtonen OP, Naukkarinen H, Outakoski J.
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [Abstract] [Full Text] [Related]

  • 3. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L.
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [Abstract] [Full Text] [Related]

  • 4. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E.
    Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
    Pflug B, Bartels M, Bauer H, Bunse J, Gallhofer B, Haas S, Kanzow WT, Klieser E, Küfferle B, Stein D.
    Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
    [Abstract] [Full Text] [Related]

  • 10. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T, Westerbergh SE, Morrison D.
    Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT.
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [Abstract] [Full Text] [Related]

  • 12. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Psychopharmacology (Berl); 1990 Sep; 102(1):76-84. PubMed ID: 1975448
    [Abstract] [Full Text] [Related]

  • 13. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD, Nair NP, Chouinard G, Awad AG, Saxena B, Jones B, McClure DJ, Bakish D, Max P, Manchanda R.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():72-7. PubMed ID: 1978496
    [Abstract] [Full Text] [Related]

  • 14. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J, Holm AC.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():158-63. PubMed ID: 1978477
    [Abstract] [Full Text] [Related]

  • 15. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA, Westenberg HG.
    Psychopharmacol Bull; 1990 Sep; 26(1):99-107. PubMed ID: 1973547
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
    Classen W, Laux G.
    Neuropsychobiology; 1989 Sep; 21(3):131-40. PubMed ID: 2575719
    [Abstract] [Full Text] [Related]

  • 17. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
    Lapierre YD, Ancill R, Awad G, Bakish D, Beaudry P, Bloom D, Chandrasena R, Das M, Durand C, Elliott D.
    J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
    [Abstract] [Full Text] [Related]

  • 18. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
    Chouinard G.
    Acta Psychiatr Scand Suppl; 1990 Oct; 358():111-9. PubMed ID: 1978469
    [Abstract] [Full Text] [Related]

  • 19. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL, Appelberg B, Kuoppasalmi K, Katila H, Rimón R.
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.